Study Reference No. - C1D04292
| Study Type | Demographic | Gender | Age | Location | Compensation |
|---|---|---|---|---|---|
| Healthy | Healthy; non-smokers for at least the past one year | Males & Females | 18 to 55 years | Mississauga, ON | $1,900 |
Study Details |
|||||||||||||
Study Purpose |
The purpose of this study is to compare the amount of active drug in your blood after a 1200 mg/60 mg dose of the reference product (R), ‘MUCINEX® DM’ (guaifenesin and dextromethorphan HBr) extended-release bi-layer tablets, 1200 mg/60 mg (RB Health (US), Parsippani, NJ 07054-0224) with the test product (T), Guaifenesin & Dextromethorphan HB} Extended-Release Tablet, 1200 mg/60 mg (Guardian Drug Company, Dayton, NJ 08810). |
||||||||||||
Study Duration |
Total duration approximately 11 days; 2 periods, 24-hr. post-dose confinement per period, 2 returns per period |
||||||||||||
Study Schedule |
|||||||||||||
General Screening |
NA |
||||||||||||
Medical Screening |
May 17, 21, 25 |
||||||||||||
Study Visit(s) |
|
||||||||||||
Follow-Up Visit(s) |
See study visits. |
||||||||||||
Other Notes |
|||||||||||||
Bring Valid Photo ID. |
|||||||||||||